SLXN SCHEDULE 13D/A: SEC filing
An amendment to a Schedule 13D was
Filed with the SEC on · accession 0001213900-26-091845
SLXN filed a SCHEDULE 13D/A (schedule 13d/a) with the SEC on Aug 19, 2026. An amendment to a Schedule 13D was filed for Silexion Therapeutics Corp, indicating a change in a major shareholder's ownership position or intentions. The stock moved -1.2% by the first close after the filing.
Summary of the filing
An amendment to a Schedule 13D was filed for Silexion Therapeutics Corp, indicating a change in a major shareholder's ownership position or intentions. The filing text available does not disclose specific details of the amendment.
Key details
How SLXN stock reacted
Close before
$0.42
Aug 18, 2026
First close after
-1.20%
$0.41
5 trading days
-12.72%
$0.36
Since filing
-64.42%
$0.15
✦ Ask GOAX AI about this filing — what it means for SLXN, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for SLXN?
Click hereFrequently asked questions
What did SLXN file with the SEC on Aug 19, 2026?
SLXN filed a SCHEDULE 13D/A (SEC filing). An amendment to a Schedule 13D was filed for Silexion Therapeutics Corp, indicating a change in a major shareholder's ownership position or intentions. The filing text available does not disclose specific details of the amendment.
How do I read a SCHEDULE 13D/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13D/A (schedule 13d/a): A report the company filed with the SEC (the US market regulator).
How did SLXN stock react to this filing?
SLXN closed at $0.42 before the filing and $0.41 on Aug 19, 2026 (-1.20%). Five trading days later: $0.36 (-12.72%).
Other SLXN SEC filings
- S-3 · Shelf registrationOct 28, 2026
- 8-K · SEC filingOct 26, 2026
- DEF 14A · Stock splitOct 5, 2026
- 8-K · Fda approvalSep 30, 2026
- 424B3 · Secondary offeringSep 29, 2026
- 8-K · SEC filingSep 29, 2026
- 8-K · Fda approvalSep 28, 2026
- SCHEDULE 13D/A · Activist campaignSep 28, 2026
- 8-K · SEC filingSep 25, 2026
- 8-K · SEC filingSep 25, 2026
Get alerts when SLXN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days